References
- Quagliarello V, Scheld WM. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med 1992; 327(12):864–72
- Tunkel AR, Scheid WM. Pathogenesis and pathophysiology of bacterial meningitis. Clin Microbiol Rev 1993; 6(2):118–36
- Schuchat A, Robinson K, Wenger JD, et al, for the Active Surveillance Team. Bacterial meningitis in the United States in 1995. N Engl J Med 1997; 337(14):970–6
- Wenger JD, Hightower AW, Facklam RR, et al, for the Bacterial Meningitis Study Group. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J Infect Dis 1990; 162(6):1316–23
- Schlech WF 3d, Ward JI, Band JD, et al. Bacterial meningitis in the United States, 1978 through 1981: the National Bacterial Meningitis Surveillance Study. JAMA 1985; 253(12):1749–54
- Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children—United States, 1987–1993. MMWR 1994; 43(8):144–8
- Zangwill KM, Vadheim CM, Vannier AM, et al. Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis 1996; 174(4):752–9
- Laboratory Centre for Disease Control, Health Canada. Notifiable diseases annual summary 1994. Canada Commun Dis Rep 1997; 23S9:28–30
- Butler JC, Hofmann J, Cetron MS, et al. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996; 174(5):986–93
- Jackson LA, Wenger JD. Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989–1991. MMWR CDC Surveill Summ 1993; 42(2):21–30
- Geiseler PJ, Nelson KE, Levin S, et al. Community-acquired purulent meningitis: a review of 1,316 cases during the antibiotic era, 1954–1976. Rev Infect Dis 1980; 2(5):725–45
- Pomeroy SL, Holmes SJ, Dodge PR, et al. Seizures and other neurologic sequelae of bacterial meningitis in children. N Engl J Med 1990; 323(24):1651–7
- Gray LD, Fedorko DP. Laboratory diagnosis of bacterial meningitis. Clin Microbiol Rev 1992; 5(2):130–45
- Spanos A, Harreil FE Jr, Durack DT. Differential diagnosis of acute meningitis: an analysis of the predictive value of initial observations. JAMA 1989; 262(19):2700–7
- Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med 1997; 336(10):708–16
- John CC. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin Infect Dis 1994; 18(2):188–93
- Meningitis Study Group. Dexamethasone therapy for children with bacterial meningitis. Pediatrics 1995; 95(1):21–8
- Townsend GC, Scheld WM. The use of corticosteroids in the management of bacterial meningitis in adults. J Antimicrob Chemother 1996; 37(6):1051–61
- 1997 Red Book Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, I11: American Academy of Pediatrics, 1997:220–4, 357–61
- Centers for Disease Control and Prevention. Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1993; 42(RR-13):1–15
- Centers for Disease Control and Prevention. Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46(RR-5):13–21
- Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46(RR-8):1–24